Skip to main content
. 2021 Nov 5;11(21):e4236. doi: 10.21769/BioProtoc.4236

Figure 5. Neutralisation of SARS-CoV-2 PV entry into target cells (HEK 293T/17 expressing ACE2 and TMPRSS2) using reference plasma panel from NIBSC or neutralising mAbs from Native Antigen.

Figure 5.

Top panel: bar chart showing IC50s for panel of convalescent plasma run in three different laboratories. Middle panel: IC50 data for panel of plasma run in three different laboratories. Bottom panel: mAb neutralisation of SARS-CoV-2 pseudotypes (Native Antigen MAB12443 and MAB12444).